Summary of your 'study carrel' ============================== This is a summary of your Distant Reader 'study carrel'. The Distant Reader harvested & cached your content into a collection/corpus. It then applied sets of natural language processing and text mining against the collection. The results of this process was reduced to a database file -- a 'study carrel'. The study carrel can then be queried, thus bringing light specific characteristics for your collection. These characteristics can help you summarize the collection as well as enumerate things you might want to investigate more closely. This report is a terse narrative report, and when processing is complete you will be linked to a more complete narrative report. Eric Lease Morgan Number of items in the collection; 'How big is my corpus?' ---------------------------------------------------------- 81 Average length of all items measured in words; "More or less, how big is each item?" ------------------------------------------------------------------------------------ 954 Average readability score of all items (0 = difficult; 100 = easy) ------------------------------------------------------------------ 5 Top 50 statistically significant keywords; "What is my collection about?" ------------------------------------------------------------------------- 27 COVID-19 14 patient 7 covid-19 6 SARS 3 psoriasis 2 procedure 2 cutaneous 1 webinar 1 virus 1 surgical 1 soap 1 skin 1 propolis 1 nasal 1 mask 1 isotretinoin 1 infection 1 hand 1 global 1 doctor 1 disease 1 dermatology 1 dermatitis 1 covid19 1 box 1 article 1 application 1 aesthetic 1 Turkey 1 PPE 1 PASI 1 Onychomycosis 1 N95 1 Köebner 1 Kawasaki 1 ICU 1 Department 1 DIC 1 DHH 1 CoV-2 1 CLL 1 CD147 1 Andrea 1 AGEP 1 ACE2 Top 50 lemmatized nouns; "What is discussed?" --------------------------------------------- 1128 patient 443 % 430 disease 361 infection 327 case 308 treatment 296 pandemic 293 study 268 risk 264 skin 228 psoriasis 224 article 164 therapy 159 copyright 158 right 158 coronavirus 152 lesion 143 manifestation 137 dermatology 132 mask 129 drug 127 clinic 124 time 117 author 116 virus 116 use 115 procedure 106 datum 101 care 99 symptom 99 effect 98 face 97 outbreak 97 hand 97 day 95 consultation 92 period 91 journal 87 finding 87 date 84 dermatologist 83 title 82 rash 81 health 79 diagnosis 79 dermatitis 77 review 76 cord_uid 75 year 75 number Top 50 proper nouns; "What are the names of persons or places?" -------------------------------------------------------------- 647 COVID-19 224 SARS 155 CoV-2 83 Dermatol 78 COVID‐19 77 sha 73 Coronavirus 69 DOI 67 China 57 Italy 50 nan 50 Dermatology 50 DIC 46 Disease 44 pemphigus 43 Wuhan 37 • 36 May 34 al 34 Turkey 34 Table 33 COVID 32 Health 32 ACE2 31 April 30 N95 28 et 28 March 27 Pandemic 25 PCR 25 COVID19 24 ICU 24 ED 23 PPE 20 Kawasaki 20 Hospital 20 CLL 19 hydroxychloroquine 18 Infection 18 IL-23 17 st 17 mg 17 aFGF 17 TNF 17 PASI 17 Department 16 apremilast 16 Spain 16 CD147 15 rh Top 50 personal pronouns nouns; "To whom are things referred?" ------------------------------------------------------------- 286 we 245 it 62 they 49 them 20 us 20 he 15 i 9 one 7 itself 4 you 4 she 3 oneself 3 him 2 themselves 1 yourself 1 me 1 diseases-10 1 age≥75 1 afgf Top 50 lemmatized verbs; "What do things do?" --------------------------------------------- 2708 be 534 have 183 use 179 protect 157 reserve 147 increase 137 report 125 treat 119 associate 117 include 91 show 87 do 81 follow 77 consider 74 suggest 68 relate 68 present 68 base 65 cause 63 perform 63 affect 58 find 56 provide 56 covid-19 56 confirm 53 wear 53 reduce 52 make 51 lead 50 give 49 need 48 compare 47 take 46 induce 46 evaluate 43 require 41 control 38 recommend 38 hospitalize 36 see 36 declare 36 apply 35 infect 35 develop 34 know 33 limit 33 become 33 accord 32 seem 32 appear Top 50 lemmatized adjectives and adverbs; "How are things described?" --------------------------------------------------------------------- 231 not 211 covid-19 202 cutaneous 188 severe 182 also 164 - 155 high 144 clinical 137 more 131 such 119 other 117 most 111 first 103 respiratory 99 systemic 90 only 86 however 84 well 81 dermatological 78 low 76 acute 71 viral 70 dermatologic 69 ther 62 new 58 key 57 old 57 many 56 like 55 psoriatic 55 biologic 53 significant 52 common 51 inflammatory 51 general 51 chronic 51 anti 50 aesthetic 49 therefore 48 non 47 moderate 46 novel 46 human 46 due 46 atopic 44 specific 44 positive 44 as 43 surgical 42 different Top 50 lemmatized superlative adjectives; "How are things described to the extreme?" ------------------------------------------------------------------------- 29 most 17 least 16 Most 15 good 5 late 3 large 3 high 2 bad 1 safe 1 cord-353659-wtacr6qj 1 common Top 50 lemmatized superlative adverbs; "How do things do to the extreme?" ------------------------------------------------------------------------ 88 most 7 least 1 worst 1 well Top 50 Internet domains; "What Webbed places are alluded to in this corpus?" ---------------------------------------------------------------------------- 9 orcid.org 2 trends.google.com 1 www.sps.nhs.uk 1 www.nottingham.ac.uk Top 50 URLs; "What is hyperlinked from this corpus?" ---------------------------------------------------- 2 http://orcid.org/0000-0002-9615-1246 1 http://www.sps.nhs.uk/articles/summary-of-covid-19medicines-guidance-skin-disorders/ 1 http://www.nottingham.ac.uk/ 1 http://trends.google.com/trends/?geo=TR 1 http://trends.google.com/trends/?geo=IT 1 http://orcid.org/0000-0003-1589-9672 1 http://orcid.org/0000-0003-0840-1936Mohamad 1 http://orcid.org/0000-0003-0348-0620 1 http://orcid.org/0000-0002-9455-4025Mohamad 1 http://orcid.org/0000-0002-5997-2045 1 http://orcid.org/0000-0002-2390-6505Alessia 1 http://orcid.org/0000-0001-6358-9068Torello Top 50 email addresses; "Who are you gonna call?" ------------------------------------------------- 1 jacek.szepietowski@umed.wroc.pl Top 50 positive assertions; "What sentences are in the shape of noun-verb-noun?" ------------------------------------------------------------------------------- 4 patients did not 2 articles were case 2 articles were comments 2 case report covid-19 2 covid-19 is still 2 disease are generally 2 disease increased significantly 2 diseases do not 2 patient is off 2 patient is symptomatic 2 patients are frequently 2 patients were naïve 2 study showing pityriasis 2 treatment is available 1 % increased risk 1 % were aged 1 % were anosmic 1 % were hyposmic 1 % were outpatient 1 articles reporting serological 1 articles were review 1 authors gave final 1 authors have also 1 case report alert 1 case report sars 1 cases being asymptomatic 1 cases including dermatology 1 cases was higher 1 cases was significantly 1 cases were dermatology 1 cases were outpatient 1 clinic increased immediately 1 clinics was not 1 cov-2 affects atopic 1 cov-2 do not 1 cov-2 gave negative 1 cov-2 has rapidly 1 cov-2 is not 1 cov-2 is part 1 cov-2 treated antigenic 1 cov-2 was positive 1 cov-2 were not 1 covid-19 are single 1 covid-19 causes fears 1 covid-19 had cutaneous 1 covid-19 has already 1 covid-19 has anecdotally 1 covid-19 has not 1 covid-19 including social 1 covid-19 is capable Top 50 negative assertions; "What sentences are in the shape of noun-verb-no|not-noun?" --------------------------------------------------------------------------------------- 2 study had no funding 1 authors have no conflict 1 clinics was not similar 1 covid-19 found no difference 1 covid-19 has not at 1 disease have not yet 1 infections is not different 1 pandemic are no longer 1 pandemic has not yet 1 patients showed no signs 1 patients was not greater 1 procedures were not always 1 skin is not yet 1 use was not obligatory A rudimentary bibliography -------------------------- id = cord-284158-5qvq27hu author = Abdelmaksoud, Ayman title = Systemic isotretinoin therapy in the era of COVID‐19 date = 2020-05-20 keywords = isotretinoin; nasal summary = Olfactory epithelium non-neural cell types express two host receptors, ACE2 and type 2 transmembrane serine protease (TMPRSS2), that facilitate SARS-CoV-2 replication and accumulation, and subsequently central nervous system invasion which may lead to respiratory failure of COVID-19 patients. 14 Lechien et al noted that 85.6% of their patients had olfactory dysfunction (79.6% were anosmic and 20.4% were hyposmic) related to COVID-19 infection, with no significant associated rhinorrhea or nasal obstruction. 19 In nutshell, till further studies on the multifaceted pathogenesis of COVID-19 infection, we suggest low, lid-dose of isotretinoin with folic acid supplement, together with proper nasal mucosal care for isotretinoin patients. Isotretinoin treatment should be questioned in all COVID-19 suspected patients presented with nasal/olfactory dysfunction symptoms. Effect of systemic isotretinoin therapy on mucociliary clearance and nasal surface mucosa in acne patients Effects of isotretinoin on the olfactory function in patients with acne doi = 10.1111/dth.13482 id = cord-293711-qgefn164 author = Abdelmaksoud, Ayman title = Comment on “COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action” date = 2020-04-16 keywords = COVID-19 summary = apy their recommendations for treatment of patients with psoriasis at time of new COVID-19 pandemic. The authors pointed to the importance of therapeutic reassessment of all psoriatic patients, particularly those with moderate-to-severe disease, who are candidate to systemic, mostly immunosuppressive, therapies in the era of COVID-19. COVID-19 virus has neurotropic potential that partially explains the higher rate of acute respiratory distress in elderly patients. ultraviolet A1 (UVA1) phototherapy has a comparable efficacy in moderate-to-severe plaque-type psoriasis and could improve the clinical manifestations and quality of life more quickly than narrow band ultraviolet B therapy with no significant side effects, including lack of increased risk of cutaneous malignancies. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? Older adults on systemic treatment for psoriasis and risk of infection:a propensity score matched population-based study Risk of serious infection in patients receiving systemic medications for the treatment of psoriasis Should patients stop their biologic treatment during the COVID-19 pandemic doi = 10.1111/dth.13360 id = cord-295995-uabnyomr author = Abdelmaksoud, Ayman title = Sexually Transmitted COVID19 date = 2020-07-08 keywords = COVID-19 summary = key: cord-295995-uabnyomr cord_uid: uabnyomr In their study on healthy women, Yuksel and Ozgor found a significant higher sexual desire and frequencies of sexual intercourse during COVID19 pandemic compared with 6-12 months prior. 4 on 10 severely infected women with COVID-19, no SARS-CoV-2 virus was noted in their vaginal fluids. They concluded that likelihood of transmitting SARS-Cov-2 to sexual partners through vaginal fluids may be low. 5 Genital contamination with genital fluids, even with low rate, is not unexpected. Due to risk of "genital" contamination with SARSThis article is protected by copyright. They are at risk of not only STDs, but also SARS-CoV2 through genital contamination. COVID19 patients presented with PR, or known STD, should be enquired about their sexual behavior/preference, and should undergo more than a nasopharyngeal swab before considering negativity of infection. Can Covid-19 Be a Sexually Transmitted Disease? Effect of the COVID-19 Pandemic on Female Sexual Behavior SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection doi = 10.1111/dth.13982 id = cord-297400-l8fhy1hu author = Adebanjo, Ganiyat Adenike Ralitsa title = A case of dermatitis artefacta during a pandemic date = 2020-08-26 keywords = dermatitis summary = A 68-year-old woman, who had been affected by mood and anxiety disorders for many years, presented during the COVID-19 lockdown period with self-inflicted skin lesions on several part of the body. There is a plethora of skin lesions which may be associated to dermatitis artefacta and they are often endowed with non-specific pathophysiological findings 5 as in the case of our patient. On the other hand, dermatitis artefacta is usually associated to lesions which are heterogeneous in appearance and that are produced to fulfill a subconscious need to be seen as vulnerable 9 : in this case the pruritus is a consequence of the disease and not a preceding factor. We decided to report this case because in this patient dermatitis artefacta seems to be related to and appeared in coincidence with the COVID-19 emergency and lockdown. doi = 10.1111/dth.14235 id = cord-270140-omr30shm author = Albuquerque Brandão, Maria Girlane Sousa title = Clinical and histopathological findings of cutaneous manifestations of COVID19 patients date = 2020-07-07 keywords = covid19 summary = title: Clinical and histopathological findings of cutaneous manifestations of COVID19 patients The evidence was analyzed in PubMed, CINAHL, Cochrane, Web of Science and Scopus, with the search strategy (covid 19 OR covid‐19 OR corona OR coronavirus OR sars‐cov‐2) AND (cutaneous or cutaneous manifestations OR), and 17 studies were included, involving 351 cases with COVID19 and skin manifestations. To comprehend how COVID19 causes dermatological alterations, affected areas, types of cutaneous manifestations, the period of appearance, cure and histological findings can provide subsidies for the disease''s early recognition, to support a more effective clinical management of cutaneous lesions and give assistance in the screening and risk stratification 5 . The study''s object is to identify clinical and histopathological findings of cutaneous manifestations of COVID19 patients. The study''s object is to identify clinical and histopathological findings of cutaneous manifestations of COVID19 patients. Histopathological findings suggest spongiosis, thrombogenic vasculopathy and perivascular infiltration of lymphocytes. doi = 10.1111/dth.13926 id = cord-353659-wtacr6qj author = Almutairi, Nawaf title = Coronavirus Disease‐2019 with Dermatologic Manifestations and Implications: An Unfolding Conundrum date = 2020-05-09 keywords = COVID-19; SARS summary = As a nosocomial infection for hospital and nursing home patients and health care workers, it represents an extraordinary challenge. Lungs are the most severely affected organ by COVID-19 because the virus enters the host cells via the integral membrane protein angiotensin-converting enzyme 2 (ACE2), which is attached to cellular membranes in the lungs, arteries, heart, kidney, and intestines. A study of 663 COVID-19 patients from Wuhan, China stressed that patients more than 60 years old and those with chronic diseases were at enhanced risk of severe COVID-19, and more likely to die (43). Clinical Characteristics of Coronavirus Disease 2019 in China Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study doi = 10.1111/dth.13544 id = cord-277971-7upcsmg4 author = Al‐Niaimi, Firas title = COVID‐19 and dermatologic surgery: hazards of surgical plume date = 2020-05-15 keywords = surgical summary = doi = 10.1111/dth.13593 id = cord-270951-6nq3jwgr author = Amerio, Paolo title = COVID‐19 and psoriasis: Should we fear for patients treated with biologics? date = 2020-05-05 keywords = COVID-19; SARS summary = doi = 10.1111/dth.13434 id = cord-334933-br1cr8kj author = Arora, Gulhima title = Solidarity and transparency against the COVID‐19 pandemic date = 2020-04-13 keywords = COVID-19 summary = authors: Arora, Gulhima; Kroumpouzos, George; Kassir, Martin; Jafferany, Mohammad; Lotti, Torello; Sadoughifar, Roxanna; Sitkowska, Zuzanna; Grabbe, Stephan; Goldust, Mohamad 4 Amidst this somber situation, the blame of "politics of epidemics" in which politics mostly attributes to the broad effect of local, national, and international establishments, on the health consequences of communities in disease outbreaks, in Asian countries like India and Iran is challenging. It also works with member states to promote knowledge and empower communities. By working together, countries promote efficiency. Cooperation is a key weapon in the battle against COVID-19. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19) COVID-19: what is next for public health? Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts doi = 10.1111/dth.13359 id = cord-306070-2dgs5oih author = Askin, Ozge title = Cutaneous manifestations in hospitalized patients diagnosed as COVID‐19 date = 2020-06-24 keywords = COVID-19; cutaneous summary = According the statistical results the patients who were hospitalized in the intensive care unit had a higher risk of having cutaneous findings due to COVID‐19 infection. During this pandemic, several case reports, and some articles were published about cutaneous manifestations of COVID-19 infection. Comparison of cutaneus manifestations according to variables of hospitalization (ward vs intensive care unit), age, gender, RT-PCR result was performed using chi-square independence test. The relationship between PCR positivity and cutaneous findings was examined by chi-square independence test and no statistical relationship was obtained between them ( χ 2 =1.990; sd=1; p>0.05) ( Table 3) . It was determined that the patients who were hospitalized in the ICU had a higher risk of having cutaneous findings due to COVID-19 infection (Table 5) . In our study 24% of the patients who were hospitalized showed cutaneous findings during COVID-19 infection. doi = 10.1111/dth.13896 id = cord-346159-0bi2f3gb author = Babu, Bibilash title = “Thinking outside the box in COVID‐19 era”‐Application of Modified Aerosol Box in Dermatology date = 2020-06-04 keywords = box summary = In March 2020, Dr. Lai Hsien-yung, a Taiwanese doctor, devised an aerosol box to minimize risk of infection to health care personnel during high aerosol generating procedures like intubation. 5 Currently, many modifications of the original aerosol box have been proposed for application in other fields like dentistry and otorhinolaryngology. Hence, the authors propose a modified design of this aerosol box to assist in performing dermatological procedures on the face like electrocautery, microneedling with a dermapen/dermaroller, chemical peels and lobuloplasty, amongst others. The authors acknowledge that this aerosol box, just like any other device, is not 100% protective or fail proof. It has been proposed to aid in providing protection to the dermatologist, in case the patient inadvertently sneezes/coughs suddenly during a procedure. 10 Hence, we propose the use of this aerosol box, as a precautionary measure, to minimize spread of infection to the maximum possible extent. Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic doi = 10.1111/dth.13769 id = cord-273680-tqlg5bac author = Bachevski, Dimitri title = Back to the Basics: Propolis and COVID‐19 date = 2020-06-07 keywords = propolis summary = doi = 10.1111/dth.13780 id = cord-296128-kjoi54ea author = Balestri, Riccardo title = Do we have serological evidences that chilblain‐like lesions are related to SARS‐CoV‐2? A review of the literature date = 2020-08-26 keywords = CLL; SARS summary = Our review demonstrated a high prevalence of negative serological results in CLL: antibodies were observed only in a few patients, that are even less excluding those with positive IgA, not clearly involved in the pathogenesis of the disease. The outbreak of chilblain-like lesions (CLL) coincidentally to the COVID-19 pandemic is a topic of great concern 1 SARS-CoV-2 was hypothesized as the etiologic agent of CLL, initially on the basis of the temporal correlation between the "burst" of skin manifestations and the viral pandemic. However, it has been shown that CLL are not related to an acute infection, since real-time reverse transcription polymerase chain reaction (rt-PCR) tests from nasopharyngeal swabs seldom resulted positive 1-9Therefore, dermatologists'' attention shifted to the search for specific SARS-CoV-2 antibodies. The search was limited to articles published in English We included only case series, clearly declaring that a search for SARS-CoV-2 specific antibodies had been performed. Chilblain-like lesions during COVID-19 pandemic: a serological study on a case series doi = 10.1111/dth.14229 id = cord-337382-b3wd182c author = Bassi, Andrea title = At home dose escalation of Propranolol for Infantile Hemangiomas during the COVID‐19 Pandemic date = 2020-07-07 keywords = Andrea summary = Infantile hemangiomas (IH) often requires urgent evaluation and risk stratification to determine which infants need treatment and which one could be managed with continued observation (5) . As the need for early treatment could be hindered by parents'' fear to access public hospitals during the pandemic period, since the last days of February we encouraged pediatricians and colleagues to send us pictures (via email or WhatsApp) to perform a first screening of patients with higher risk IH needing beta-blocker treatment (5) . In this emergency situation, to avoid unnecessary access to our Hospital heavily engaged in the treatment of COVID-19 patients, we decided, after informed consent, to slowly increase the dose of the drug at home and to monitor the treatment by telemedicine with parents and with the referring pediatrician. Management of Infantile Hemangiomas during the COVID Pandemic doi = 10.1111/dth.13977 id = cord-348501-8cvtqj7w author = Beyzaee, Amir Mohammad title = Rituximab as the treatment of pemphigus vulgaris in the COVID‐19 pandemic era: A narrative review date = 2020-10-20 keywords = COVID-19; patient summary = As the immunosuppressive effect of rituximab, the first‐line therapy of PV, lasts more than 6 months, many concerns have raised due to the ongoing novel coronavirus disease (COVID‐19) pandemic. We performed a computer-assisted search of "PubMed" and "Google Scholar" databases up to 14 July 2020 using the keywords "anti-CD20 therapy," "pemphigus vulgaris," and "COVID-19." We also searched other related keywords such as coronavirus, rituximab, immunocompromised, immunosuppressive drugs, pathogenesis, clinical presentations, treatment, and outcome. 17, 18 Athough some studies may have reported that risk of infections is not different between AIBD patients treated with rituximab or high dose corticosteroids, 16 Coronavirus can target the central nervous system (CNS), which is protected by humoral immunity. 31 Also, Guilpain et al reported three systemic sclerosis (SSc) patients treating with rituximab, which resulted to late clinical worsening to severe pneumonia due to the COVID-19 infection. doi = 10.1111/dth.14405 id = cord-289855-11pkt4uu author = Bhargava, Shashank title = Employing dermatologists on the frontline against COVID‐19: All hands on deck date = 2020-05-13 keywords = COVID-19 summary = Healthcare providers should be recruited in critical care management depending upon their skill set and confidence level. They should receive training in simple procedures such as vascular access, straightforward intubations, proning maneuvers, and fluid management in uncomplicated patients in order to take off some of the pressure from ICU staff. As the focus shifts from containment efforts to disease mitigation, the healthcare community must step up as a whole to lend its expertise as never before. In a survey among Indian dermatologists, 57% of the respondents would consider redeployment in COVID-19 "hot zones" if a need to augment the medical workforce arises. Our patients need us to move out of our comfort zones and heed the clarion call for "all hands on deck" in order to defeat COVID-19. Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic Our thanks to all healthcare workers on the frontlines caring for our most vulnerable doi = 10.1111/dth.13420 id = cord-309195-0scmephx author = Blicharz, Leszek title = Hand eczema ‐ a growing dermatological concern during the COVID‐19 pandemic and possible treatments date = 2020-05-08 keywords = covid-19 summary = title: Hand eczema ‐ a growing dermatological concern during the COVID‐19 pandemic and possible treatments 3 Regardless of HE etiology, exposure to detergents and soaps, frequent hand washing (>20 times/day) and the use of occlusive gloves are all well-known risk factors of disease onset This article is protected by copyright. Topical steroids such as clobetasol propionate and mometasone furoate are usually the first-choice anti-inflammatory agents, though they may interfere with the skin barrier regeneration and thus their long-term This article is protected by copyright. 6 Lastly, systemic agents should be considered in severe cases refractory to topical treatment. Therapeutic options include short courses of systemic steroids during disease exacerbations, oral retinoids, e.g. alitretinoin, acitretin, and immunosuppressants such as methotrexate, azathioprine, and cyclosporine A. 6 Despite the lack of evidence on the increased risk of severe COVID-19 in immunocompromised patients, 7, 8 we believe that the first-line systemic treatment should involve oral retinoids followed by immunosuppressants in recalcitrant cases. Hand eczema: treatment doi = 10.1111/dth.13545 id = cord-348430-8xk4dt7t author = Bragazzi, Nicola Luigi title = COVID‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration date = 2020-05-28 keywords = covid-19; patient summary = To the best of our knowledge, there is a dearth of data concerning the COVID-19 perceptions of dermatological patients under biologics, a therapy traditionally associated to an increased risk of infections. • in psoriatic patients: Psoriasis Area Severity Index (PASI) 14 ≥10 and or Disease Activity index for PSoriatic Arthritis" (DAPSA) 15 Remarkably, in these departments patients undergoing a biological therapy were affecting only by psoriasis (PsO), or atopic dermatitis (AD) or hidradenitis suppurativa (HS). Despite only 8.1% thought that biologics expose them to a moderate to severe risk to contract SARS-CoV2, 18.4% and 21.4% of the whole patients declared that they have assessed the possibility to discontinue or modify the dosage of the current biologic therapy, respectively. 29 In literature, both psoriasis, atopic dermatitis and hidradenitis suppurativa displayed an higher risk of respiratory comorbidities; in accord with this evidence 30% of the interviewed patients thought that their dermatological disease could increase the SARS-CoV2 infection risk. doi = 10.1111/dth.13508 id = cord-335104-8b2tpbsh author = Carugno, Andrea title = Coronavirus disease 2019 (COVID‐19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17? date = 2020-07-27 keywords = COVID-19 summary = authors: Carugno, Andrea; Gambini, Daniele Mario; Raponi, Francesca; Vezzoli, Pamela; Robustelli Test, Elisa; Arosio, Marco Enrico Giovanni; Callegaro, Annapaola; Sena, Paolo title: Coronavirus disease 2019 (COVID‐19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17? Various cutaneous manifestations have been observed in COVID-19 patients 1 and there has been worldwide concern among patients undergoing biologic therapies. [2] [3] [4] We report our experience with a COVID-19 psoriatic patient treated with anti-interleukin-(IL)-17 who developed a late onset rash. About 5 weeks later, he referred to us due to the rapid onset of a mild pruritic erythematooedematous morbilliform rash, rapidly spreading from arms to trunk and lower limbs; he also showed an initial flare-up of his psoriasis The patient developed a mild form of COVID-19, even though his age and comorbidities are most typically associated with poorer prognosis. Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times doi = 10.1111/dth.14011 id = cord-289819-1kji8bbn author = Chang, Michelle J. title = Caring for Deaf and Hard of Hearing Patients in Dermatology during the COVID‐19 Pandemic date = 2020-08-14 keywords = DHH summary = title: Caring for Deaf and Hard of Hearing Patients in Dermatology during the COVID‐19 Pandemic Safety procedures have been implemented to protect patients and providers, some of which may interfere with effective communication for deaf and hard of hearing (DHH) patients, who already face significant challenges. In this letter, we make recommendations for mitigating communication barriers for DHH dermatological patients during the COVID-19 pandemic. 4 To limit risk of COVID-19 transmission, dermatology practices have dramatically reduced inperson visits and increased utilization of telemedicine and telephone calls, 5 posing significant and unique challenges to DHH patients. If an interpreter is not available for video conferencing, dermatologists should facilitate the encounter via telephone, so that DHH patients may use their preferred telecommunication relay service. The COVID-19 pandemic requires that dermatologists be creative in providing DHH patients with timely and effective care. Overcoming Additional Barriers to Care for Deaf and Hard of Hearing Patients During COVID-19 doi = 10.1111/dth.14185 id = cord-348846-mfhxac5c author = Coletto, Lavinia Agra title = Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID‐19 days date = 2020-05-02 keywords = psoriasis summary = key: cord-348846-mfhxac5c cord_uid: mfhxac5c Diabetes and metabolic syndrome are acknowledged as associated with PsA and psoriasis 4 ; these comorbidities in the setting of a poorly controlled disease may worsen due to inflammation itself. In conclusion, before interrupting a chronic therapy, even if patients with PsA have an increased risk of comorbidities and serious infections compared with patients with psoriasis, 7 we suggest evaluating not only the infectious profile of immunosuppressants but also the underlying inflammatory nature of psoriatic disease itself, especially if severe and/or associated with articular involvement. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? Risk of serious infection with biologic and systemic treatment of psoriasis: results from the psoriasis longitudinal assessment and registry (PSOLAR) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. The incidence and predictors of infection in psoriasis and psoriatic arthritis: results from longitudinal observational cohorts doi = 10.1111/dth.13415 id = cord-322332-0pi3wcv5 author = Conforti, Claudio title = Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against IL‐6 in COVID‐19 outbreak date = 2020-05-15 keywords = COVID-19 summary = An open-label nonrandomized clinical trial suggested that chloroquine and its less toxic metabolite, hydroxychloroquine, may be effective against COVID-19. In fact, in addition to its well-defined antibiotic effects (bacteriostatic action by inhibition of bacterial protein synthesis), in vitro studies have shown doxycycline to exert anti-inflammatory effects at low (20-40 mg/day) and high (100 or 200 mg/day) doses with inhibitory action on metalloproteases and modulating effects of pro-inflammatory cytokines IL-6, IL-8, and tumor necrosis factor-alpha. 7 The anti-inflammatory properties of doxycycline and other components of tetracycline has been demonstrated for several inflammatory airway diseases, including, acute respiratory distress syndrome. 8 Thereby, low doxycycline doses have been shown to be more effective than high doses to prevent induction of pro-inflammatory cytokines (such as IL-6) in inflammatory diseases. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial doi = 10.1111/dth.13437 id = cord-343739-t3z6ghyp author = Conforti, Claudio title = Management of advanced melanoma in the COVID‐19 era date = 2020-05-14 keywords = covid-19 summary = key: cord-343739-t3z6ghyp cord_uid: t3z6ghyp For patients undergoing treatment with immunosuppressive or immunomodulating drugs for chronic dermatological diseases, such as psoriasis, several guidelines suggest to assess on a case-by-case basis the initiation of a new therapy with a biological drug as well as the possible suspension in case of positivity. 2 Apart from psoriasis, which can sometimes also be treated in an alternative way, we must focus our attention on the most fragile patients in dermatology, that is, oncologic patients suffering from advanced melanoma. In fact, we should remember that cancer-related treatments may cause immunosuppression, and the first available data suggest that patients with cancer have a risk of excess mortality due to SARS-CoV-2. Coronavirus disease 2019 (COVID-19): facts and controversies COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? Oncology practice during the COVID-19 pandemic AIOM, Rischio infettivo da Coronavirus Covid-19: indicazioni per l''oncologia Cancer patient management during the covid-19 pandemic doi = 10.1111/dth.13444 id = cord-302571-vb9ks4mq author = Damiani, Giovanni title = Biologics increase the risk of SARS‐CoV‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration date = 2020-05-19 keywords = ICU summary = title: Biologics increase the risk of SARS‐CoV‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration With respect to the general population of Lombardy, patients on biologics were at higher risk to test positive for COVID‐19 (odds ratio [OR] 3.43 [95% confidence interval (CI) 2.25‐5.73], P < .0001), to be self‐quarantined at home (OR 9.05 [95% CI 5.61‐14.61], P < .0001) and hospitalized (OR 3.59 [95% CI 1.49‐8.63], P = .0044), however, not increased risk of ICU admission or death were found. PsO patients on biologics displayed higher risk to be infected and to be hospitalized/self-quarantined at home, but ICU hospitalization and death did not differ from the general population. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration doi = 10.1111/dth.13475 id = cord-340283-5w444i1g author = Das, Anupam title = Erythematous‐oedematous type of chilblain‐like lesions and COVID‐19 : an Indian perspective date = 2020-06-27 keywords = COVID-19 summary = Therefore, the temporal association, complaints of the peculiar neurological sensation followed by development of erythema and swelling in our patients, supports the probable association of the cutaneous manifestations, with COVID-19. 6 In one of the largest series published from Spain, cutaneous manifestations were pseudochilblains (19%), vesicular eruptions (9%), urticaria (19%), maculopapular rashes (47%) and livedo (6%). 7 In another series published from Italy, authors noticed an outbreak of chilblain-like lesions in Italy contemporary to COVID-19 epidemic, who reported two varieties of lesions, namely erythematous-oedematous type and blistering type. Cutaneous manifestations in COVID-19: a first perspective A dermatologic manifestation of COVID-19: transient livedo reticularis Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Chilblain-like lesions on feet and hands during the COVID-19 Pandemic doi = 10.1111/dth.13912 id = cord-276549-r5l4pse8 author = Dastoli, Stefano title = Are erythema multiforme and urticaria related to a better outcome of COVID‐19? date = 2020-06-09 keywords = COVID-19 summary = doi = 10.1111/dth.13681 id = cord-297532-ktiwfcop author = De Fata Salvatores, Gaia title = Patients with bullous disorders during COVID‐19 period: management and adherence to treatment date = 2020-05-26 keywords = patient summary = doi = 10.1111/dth.13697 id = cord-301107-0njnjqeb author = Dursun, Recep title = The Clinics of HHV‐6 infection in COVID‐19 pandemic: Pityriasis rosea and Kawasaki disease date = 2020-05-31 keywords = Kawasaki summary = After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Herein, we wanted to aim to evaluate whether two diseases (Pityriasis rosea and Kawasaki disease), in which Human Herpesvirus 6 (HHV-6) was held responsible for etiopathogenesis, after the COVID-19 pandemic. After pandemic, the number of patients with Pityriasis rosea increased significantly in patients who applied to the dermatology outpatient clinic (p:0,000). After pandemic, the number of patients with Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic (p:0,009). In our study, it was found that the rate of Pityriasis rosae patients who applied to the dermatology outpatient clinic this year during the pandemic period increased approximately 5 times compared to the same time last year. In our study, there was a 10-fold increase in the rate of patients with Kawasaki disease who applied to the dermatology outpatient clinic compared to the previous year. doi = 10.1111/dth.13730 id = cord-299681-smhto9em author = Elsaie, Mohamed L. title = Herpes zoster might be an indicator for Latent COVID 19 infection date = 2020-05-23 keywords = patient summary = In this report we describe two cases COVID infection who first presented with herpes zoster. We are here by suggesting that the clinical presentation of HZ at the time of the current pandemic even in patients giving mild or no suggestive history of upper respiratory symptoms should be considered as an alarming sign for a recent subclinical SARS CoV2 infection. Most patients with COVID-19 exhibit mild to moderate symptoms, but approximately 15% of the cases progress to severe pneumonia and about 5% eventually develop acute respiratory distress syndrome (ARDS), septic shock and/or multiple organ failure (3, 4) . We present two cases of clinically diagnosed Herpes zoster infection attending two different clinics, both patients'' showed no or mild symptoms of COVID 19 infection and denied any history of contact with known or suspected COVID19 cases. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan doi = 10.1111/dth.13666 id = cord-340029-iv2x1vap author = Farabi, Banu title = Comment on “Psoriasis, COVID‐19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment” date = 2020-06-14 keywords = covid-19 summary = showed that there is no death due to COVID-19 and only one hospitalization, fully recovered amongst the patients with chronic plaque psoriasis receiving a biological treatment and renal transplant recipients who were under immunosuppressive therapies (4) . Since, we do not have much data on biologics in psoriasis patients effecting COVID-19 disease course, current data suggests that there is no increase morbidity/ mortality amongst these patients. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies doi = 10.1111/dth.13840 id = cord-333684-j1sg46w9 author = Filippi, Federica title = COVID‐19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy date = 2020-06-10 keywords = patient summary = About 750 psoriatic patients assuming biological therapy currently refer to our psoriasis outpatient service, in Sant''Orsola-Malpighi University Hospital, Bologna (Italy), with an average of 80 patients visited weekly. In the screening and monitoring of psoriatic patients, we follow the latest Italian guidelines 3 : blood tests (full blood count, creatinine and electrolytes, liver function tests, serum lipids, fasting glucose) as well as psoriasis disease severity assessment and general physical examination should be performed at baseline and periodically afterwards, on average every 3-4 months, based on clinical judgement, in particular extension of the disease (body surface area, nail involvement, critical areas localization), diagnosis of arthropatic psoriasis, comorbidities and other associated symptoms. Non-urgent blood tests were also suspended, including monitoring in psoriatic patients undergoing biological therapy 7 . If this is not so, it could be the starting point for a further lengthening of the monitoring time of psoriatic patients considered responders to biological therapy. doi = 10.1111/dth.13805 id = cord-280774-r2xm164s author = Gallizzi, Romina title = Management of pernio‐like cutaneous manifestations in children during the outbreak of covid‐19. date = 2020-09-19 keywords = CoV-2; SARS summary = The increased number of cases of pernio-like lesions compared to the cases per year we usually observe, the mild temperatures of those months in Southern Italy and the concomitant lockdown, led us to hypothesize a possible correlation with SARS-CoV-2 infection. This is useful to highlight, as in our case, the D-dimer of our patients was weakly increased, a condition perfectly correlated with the mild symptoms of SARS-CoV-2 putative infection presented. In a report of 19 adolescent patients with a clinical diagnosis of pernio-like lesions nasopharyngeal swab and IgG serology for SARS-CoV-2 nucleocapsid protein were negative. Why some children who come into contact with the SARS-CoV-2 do not develop striking respiratory symptoms but present pernio-like lesions with negativity on diagnostic tests? This pathogenic mechanism could explain the appearance of pernio-like lesions due to SARS-CoV-2 infection. In conclusion, we think there is a correlation between pernio-like lesions and SARS-CoV-2 infection, but further studies are needed to prove it. doi = 10.1111/dth.14312 id = cord-274090-eab7i4f6 author = Gaspari, Valeria title = Can Covid‐19 be a sexually transmitted disease? Posterity will judge date = 2020-05-24 keywords = SARS summary = The knowledge of all possible modes of transmission of SARS-CoV-2 infection is the key to improving both the identification of the asymptomatic population and the necessary isolation measures in order to further flatten the curve. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients (66.67%) has already been demonstrated in recent studies in Wuhan, without being statistically related to gastrointestinal symptoms and/or disease severity. Moreover, the positivity for SARS-CoV-2 on vaginal swab raises the possibility of both sexual and mother-to-child transmission 7 , although further studies are needed on these issues since no definitive proofs have been found. A further step would be adding SARS-CoV-2 serology, pharyngeal, anal and vaginal swabs to our usual STD screening also in the asymptomatic population, in order to identify positive cases and to confirm the SARS-CoV-2 orogenital route of transmission. SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes doi = 10.1111/dth.13676 id = cord-320862-ua69gcxv author = Giacalone, Serena title = The fear of COVID‐19 infection is the main cause of the new diagnoses of hand eczema: report from the frontline in Milan date = 2020-05-20 keywords = hand summary = The Center for Disease Control and prevention (CDC) asserted that hand washing and surface decontamination are primary measures to reduce COVID-19 propagation [1] . In parallel, recent studies revealed an increased incidence of hand eczema (HE) in health care workers [2] , as well as among general population [3] . The remaining ten patients were suggested two or three daily applications of reparative hand cream This article is protected by copyright. Above all, we focused our attention on giving information about rational of hand hygiene and preventing clinical relapses with daily application of moisturisers in association with barrier creams [5] . Because it has been demonstrated that a damaged skin barrier could be a gateway for COVID-19 [6] , to preserve a high compliance in CDC actions recommended for the prevention of person-to-person viral transmission, dermatologist have the role to educate people to maintain "healthy hands". doi = 10.1111/dth.13630 id = cord-281216-7t647fww author = Goldust, Mohamad title = Performing dermoscopy in the COVID‐19 pandemic date = 2020-05-05 keywords = SARS summary = A novel coronavirus (SARS-CoV-2) that has recently emerged from China in late 2019 has become a global pandemic. Recent data has suggested that SARS -COV2 can remain viable in aerosols for multiple hours. However, cross-infection is a significant concern with contact dermoscopy especially during a viral pandemic. to disinfect hands with 60-70% isopropyl alcohol, provide verbal consents, and wear surgical masks before entering procedure rooms. It is advisable to wear adequate eye protection (goggles or visor) considering that exposed mucous membranes and unprotected eyes can increase the risk of SARS-CoV2 transmission. 4 Mucous membrane dermoscopy should only be performed when the examination has fundamental significance for therapeutic decisions. Aerosol and Surface Stability of SARSCoV-2 as Compared with SARS-CoV-1 Identifying gram-positive cocci on dermatoscopes and smartphone adapters using MALDI-TOF MS: a cross-sectional study 2019-nCoV transmission through the ocular surface must not be ignored doi = 10.1111/dth.13506 id = cord-302676-aarcjyia author = Goldust, Mohamad title = Where do we stand as dermatologists in combat with COVID‐19 date = 2020-05-22 keywords = COVID-19 summary = The novel corona virus disease (COVID-19 due to SARS-CoV-2) which began in Wuhan, China in late December 2019, quickly spread to involve the rest of the world within a span of few weeks. [1] [2] [3] Hygiene measures are of paramount importance to combat transmission of COVID-19 including social distancing, meticulous hand hygiene measures like frequent hand washing, avoiding touching the face and wearing masks. Healthcare workers, who are at high risk of acquiring the infection are advised to wear personal protective equipment (PPE). aggravate during periods of stress, like psoriasis, eczema, atopy and neurodermatitis can also flare up either in health care workers or in patients. The patient presented with petechiae rash and lab reports showed thrombocytopenia, the two common features of dengue. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic doi = 10.1111/dth.13638 id = cord-322718-zpf2ri9k author = Goldust, Mohamad title = Dermatology and specialty rotations: COVID‐19 may reemphasize the importance of internal medicine date = 2020-07-11 keywords = COVID-19 summary = title: Dermatology and specialty rotations: COVID‐19 may reemphasize the importance of internal medicine In most countries including Switzerland, dermatology residency entails five years of training including ward rounds, inpatient care, outpatient consultation, mandatory dissertations, research projects, case presentations, scientific writing and specialists exams -but all pertinent to the subject. Even in the armed forces teaching institutes, serving as a general practitioner is mandatory before dermatology residency to become trained in, internal medicine and infectious diseases. In brief, internal medicine rotations should be made mandatory for dermatologists as this foundation may of use not only for our professional routine but also for exceptional healthcare crisis such as COVID-19. This assumption may reinforced with the SkinSerious Campaign launched by the American Academy of Dermatology which reemphasizes the integral role of dermatologists in health care. Safety Measures in Dermatology Help Minimize Spread of COVID-19 Dermatology Residents and the Care of COVID-19 Patients doi = 10.1111/dth.13996 id = cord-328718-j9p7ahl8 author = Goldust, Mohamad title = Skin cancer and COVID‐19 date = 2020-07-23 keywords = COVID-19 summary = Some of the worst affected patients include those with chronic illnesses like skin cancers (basal cell carcinoma, squamous cell carcinoma and melanoma). Due to minimal availability of public transport and doctors in regular clinics, several skin cancer patients are going undiagnosed, leading to delayed diagnosis resulting in worsening of its grade and prognosis. Many patients with skin cancer are already immunosuppressed, thus increasing their susceptibility to various infections including COVID-19. 5 Thus, COVID-19 induced stress may predispose patients to squamous cell carcinoma. Newer anti-cancer molecules like immune checkpoint inhibitors (pembrolizumab, ipilimumab, nivolumab) are being used in melanoma 6 but there are reports of pembrolizumab induced neutropenia. 7 This weakens the immune system of patient leading to increased risk of COVID-19. 8 The treatment regimens are also being modified to decrease the need of hospital visits by these patients to reduce the spread of COVID-19 viz. Chronic stress and susceptibility to skin cancer. doi = 10.1111/dth.14050 id = cord-296022-yl3j2x5p author = Gupta, Mrinal title = COVID‐19 and economy date = 2020-04-08 keywords = global summary = key: cord-296022-yl3j2x5p cord_uid: yl3j2x5p concern, COVID-19 is having major consequences on the world economy, and experts have predicted that COVID-19 will lower global gross domestic product growth by one-half a percentage point for 2020 (from 2.9% to 2.4%). The whole world is now a single global community, where any major happening in one part is bound to have repercussions in rest of the world. 2 Chinese government, in order to control the spread of the disease, had to close the major production centers and as China being a manufacturing hub, led to disruption in the global supply chain which affected almost all sectors ranging from pharmaceuticals to automobile. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19) How is the world responding to the 2019 coronavirus disease compared with the 2014 west African Ebola epidemic? The importance of China as a player in the global economy The global macroeconomic impacts of COVID-19: Seven scenarios doi = 10.1111/dth.13329 id = cord-315166-ga6e3lqp author = Isoletta, Eugenio title = Emergency accesses in Dermatology Department during the Covid‐19 pandemic in a referral third level center in the north of Italy date = 2020-07-18 keywords = covid-19 summary = Since February 21 st , 2020, when the first case in Italy was confirmed, an overwhelming number of SARS-CoV-2 infections were detected and hospital organizations have adapted to cope with the emergency, 1,2 . We performed a retrospective review of all dermatological consultations in the ED of IRCSS San Matteo between February 22 nd (date of the first proven autochthonous Covid-19 case) and May 3 rd (date of the end of the "phase 1" of the lockdown). Our aim was to evaluate the impact of the ongoing pandemic on the number of dermatological ED consultation, on the severity of cases presented to the ED with cutaneous symptoms, and on the diagnoses at discharge. The first finding emerging from our data was a dramatic reduction in the request for dermatological ED consultations during the COVID pandemic comparing to the same period in 2019, from 164 patients to 33, with an absolute difference of -79.9 percentage points ( Table 1 ). doi = 10.1111/dth.14027 id = cord-323082-p0km31by author = Jakhar, Deepak title = Callous attitude toward doctors during COVID‐19 date = 2020-07-07 keywords = doctor summary = key: cord-323082-p0km31by authors: Jakhar, Deepak; Kaur, Ishmeet title: Callous attitude toward doctors during COVID‐19 date: 2020-07-07 journal: Dermatol Ther DOI: 10.1111/dth.13885 sha: doc_id: 323082 cord_uid: p0km31by The government condemns and issues several notices to stop such acts, but in the absence of a strict law these attacks do not seem to be stopping. More importantly, it is for the general population to understand that doctors do their best, even risk their lives, to deliver the health care services. The authors declare no potential conflict of interest. Death from COVID-19 of 23 health care workers in China More Than 60 Doctors in Italy Have Died in COVID-19 Pandemic Coronaphobia: COVID-19 Warriors Live in Torment Doctor Assaulted Over Death of COVID-19 Patient Coronavirus: India Doctors ''Spat at and Attacked Indian Doctors have an Unexpected Problem While Battling Coronavirus Chennai: Family of Doctor Who Died Due to COVID-19 Not Allowed to Bury Him doi = 10.1111/dth.13885 id = cord-258039-046s47v6 author = Jindal, Anuradha title = Dermatological procedures amidst Covid‐19: when and how to resume date = 2020-05-12 keywords = procedure summary = doi = 10.1111/dth.13561 id = cord-317323-wp3vh4c1 author = Kandhari, Rajat title = The changing paradigm of an aesthetic practice during the COVID‐19 pandemic: An expert consensus date = 2020-10-28 keywords = COVID-19; N95; PPE summary = It is pertinent that the physician today understands the infection, disinfection measures, and personal protective equipment to reduce chances of viral transmission and provide safe clinical settings for oneself, the staff and the patients. While certain guidelines and expert consensus have recently been published [2] [3] [4] providing an overview of "safe" working protocols, it appears that we are evolving every day in our practices with respect to "what works" and "what does not." Our article aims to bridge the gap between guidelines and in-clinic experiences to provide a set of best practices to follow for aesthetic procedures after reopening our practices. In contrast, the occurrence of airborne transmission is due to smaller particles, which maybe suspended in the air for long periods and can infect people distant from the source (eg, AGP''s)PPE consists of protective apparel and/or equipment designed for providing protection against infectious agents to HCW''s and their patients. Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings doi = 10.1111/dth.14382 id = cord-323965-6mzzibj8 author = Kapoor, Krishan Mohan title = COVID‐19 Pandemic: Consensus Guidelines for Preferred Practices in an Aesthetic Clinic date = 2020-05-16 keywords = aesthetic; covid-19; patient; procedure summary = A set of consensus guidelines for ''preferred practices'' in aesthetic clinics is proposed in this paper for maintaining a high level of safety for the patients coming to the clinic for treatment as well as for the doctors/ therapists performing the procedures. • Small procedure rooms 12 with limited or no natural ventilation • Central air conditioning having a single cooling unit and multiple room vents in most aesthetic clinics, without HEPA (High Efficiency Particulate Air) filtration as present in most operating rooms 13 • Inadequate distance between the patient and treating doctor or therapist 14 • Some of the procedures could take a long time with a patient, e.g., Full Face Ultherapy treatment, Whole body laser hair reduction • Repeated handling of equipment like touch screen, desktop, patient chairs by doctor/therapist and initial screening and handling of patient forms, cash, credit card by the front office staff doi = 10.1111/dth.13597 id = cord-322963-r0fhnpdn author = Katerina, Damevska title = Impact of COVID‐19 outbreak on dermatology services: Dermatology in isolation date = 2020-05-22 keywords = dermatology summary = 1 We present a unique experience from Republic of Macedonia where an abrupt interruption of the dermatology service on a national level, and the COVID-19 outbreak, occurred simultaneously, with a significant impact on the quality of care. The fourth diagnosed case of COVID-19 in the Republic of Macedonia was a dermatologist employed at the University Clinic for Dermatology in Skopje, the only tertiary care hospital in the country. Only 9 dermatologists in secondary care could resume practice in the period from In an effort to discover which of the dermatological conditions demanded immediate attention, we conducted a survey where we asked colleagues about the number and reasons for teledermatological consults. 5, 6 Our survey contributes by presenting the dermatoses, which demanded dermatological consult and which were a diagnostic and therapeutic challenge to the GPs and other specialties. Inpatient care for dermatological patients during SARS-CoV-2-a case report from Portugal doi = 10.1111/dth.13552 id = cord-340474-hbcu72cm author = Kaushik, Akanksha title = Urticaria in the times of COVID‐19 date = 2020-06-12 keywords = COVID-19 summary = 2 As per one review, 88/256 (34.3%) patients across 16 studies demonstrated skin manifestations, mostly as erythematous maculopapular rash, urticaria or vesicular rash. 4 While there was a report of one COVID-19 patient presenting with urticaria and dry cough without any fever, 5 the timing of appearance of urticaria was variable, with lesions appearing before, with, as well as >48 hours after onset of fever. [6] [7] [8] [9] Although skin manifestations did not correlate with disease severity in most case reports, 2,6 the prospective This article is protected by copyright. study from Spain suggested that presence of urticaria and maculopapular lesions were associated with more severe COVID 19 illness and a higher (2%) mortality. With an eye on the reported literature, we make a few suggestions regarding urticaria in This article is protected by copyright. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection doi = 10.1111/dth.13817 id = cord-255583-kgph7lr8 author = Kutlu, Ömer title = A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic? date = 2020-04-24 keywords = psoriasis summary = doi = 10.1111/dth.13383 id = cord-319820-eb5y7gxj author = Kutlu, Ömer title = Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID‐19 pandemic date = 2020-07-02 keywords = Turkey summary = The terms "acne", "hair loss", "eczema", "genital warts", "molluscum contagiosum", "botox", "skin cancer", "sunscreen" were analyzed on first April, first May, first June 2020, and the corresponding period of the previous year in Turkey and Italy by using Google Trends. The relative change of search term "acne" was +10, +29, +13/ ‐1, +17,+33, "hair loss" was +14, +40, +16/+3, +16, +15, and "eczema" was +2, +34, −4/ +3, +25, +18, on the other hand, the relative change of the "genital warts" was −15, −48, +10/ ‐44, −30, +18 and "molluscum contagiosum" was −12, −2, −4/ ‐4, −1, −12 while "botox" was, −10, −43, −8/ ‐41, −31, +4, "skin cancer" was −27, −38, −38/−22,+33, −7 and sunscreen was −6, −25, −71/−13,0,‐45 in Turkey/Italy on 1 st April, 1 st May, and 1 st June, 2020, respectively. The search terms including "acne", "eczema", "hair loss" appears to be increasing while "molluscum contagiosum", "genital warts" "botox", "skin cancer", and "sunscreen" decreasing in the era of the COVID‐19 pandemic. doi = 10.1111/dth.13949 id = cord-324794-h08uzro4 author = Kutlu, Ömer title = The explosion in scabies cases during COVID‐19 pandemic date = 2020-05-23 keywords = covid-19 summary = 2, 3 Recently, we reported that not number but percentages of patients with scabies, psoriasis, urticaria, and scabiesrelated visits to dermatology outpatient clinic increased immediately ten days after COVID-19 pandemic. In the literature, the increasing number of patients with scabies during COVID-19 pandemic has not yet been reported in European countries. Given Turkey''s cultural structure, the lifestyle such as living in the same household with a large number of people, which has become more common due to pandemic-related temporary migration is more frequent than European countries. On the other hand, although the number of patients who requests for outpatient clinics that are not directly related to the pandemic cases decreased in Turkey, most of the hospitals continued to provide healthcare services in all branches of medicine including dermatology. 4 All these factors may be a possible explanation of why Turkey has more scabies cases than European countries. The effect of the "stay-athome" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak doi = 10.1111/dth.13662 id = cord-309813-qojacnli author = Lipner, Shari R. title = Recommendations for Diagnosis and Treatment of Onychomycosis During the COVID‐19 Pandemic date = 2020-05-30 keywords = Onychomycosis summary = 1 Prior to the COVID-19 pandemic, clinical examination, dermoscopy, and mycological examination were recommended for all patients with suspected onychomycosis, followed by a discussion of appropriate treatment options. 2 However, with prevalence of COVID-19, non-urgent inperson visits are deferred, and telemedicine may be utilized to address some aspects of onychomycosis diagnosis and treatment. Onychomycosis treatment guidelines prior to the COVID-19 pandemic are no longer applicable. Telemedicine can be used for initial consultation of patients with onychodystrophy and topicals prescribed for tinea pedis if indicated; patients with confirmed onychomycosis can be monitored for clear nail growth and side effects. Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine for Onychomycosis doi = 10.1111/dth.13709 id = cord-318866-3arxrm8m author = Magnano, M. title = Psoriasis, COVID‐19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment date = 2020-05-30 keywords = COVID-19 summary = The management of psoriatic patients under biologics during SARS-CoV-2 outbreak is of great concern, as well as the outcome of the COronaVirus DIsease (COVID-19) in this population. On a pool of 720 psoriatic patients followed by our 3 referral centers for severe psoriasis, we registered 9 swab-confirmed cases of SARS-CoV-2 infection (Table 1) . 1 , who concluded that, despite the cardiovascular and metabolic comorbidities affecting psoriatic patients and also representing risk factors for severe COVID-19, patients seldom required hospitalization. 2 The appropriateness of withdrawing biologic therapies preventively in psoriatic patients is still debated and it is also unclear whether their use influences the course of COVID-19 or not. 4 The psoriatic population treated with biologic therapies is on average young 5 , since elderly patients with multiple comorbidities are usually excluded from systemic treatments. Although this case series is limited, we evidenced that ARDS can represent a complication also in patients under biologics. doi = 10.1111/dth.13706 id = cord-297295-lsewt5t2 author = Matusiak, Łukasz title = Inconveniences due to the use of face masks during the COVID‐19 pandemic: a survey study of 876 young people date = 2020-05-14 keywords = mask summary = title: Inconveniences due to the use of face masks during the COVID‐19 pandemic: a survey study of 876 young people Personal protective equipment (PPE) can cause harm to the skin (2) (3) (4) (5) , however, little is known on inconveniences of face masks wearing (4) (5) (6) (7) . Interestingly, other skin bothersome reactions related to wearing of face masks were reported less often (itch -7.7%, skin irritation -0.9%). In the model of logistic regression analysis we found that wearing surgical masks among the other types of masks showed significantly lower risk for the development of most common bothersome issues, as difficulty in breathing, warming/sweating, glasses misting up, slurred This article is protected by copyright. In contrast, cloth masks use was related to higher risk of difficulty in breathing (OR=1.56), warming/sweating (OR=1.31), glasses misting up (OR=1.92), slurred speech (OR=1.86) and itch (OR=2.99). doi = 10.1111/dth.13567 id = cord-338135-zwo7e7gy author = Melis, Daniele title = Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID‐19 pandemic date = 2020-05-30 keywords = PASI; patient summary = Apremilast is an innovative small-molecule phosphodiesterase 4 inhibitor that has been approved for the treatment of moderate-to-severe plaque psoriasis in adult patients; it has a remarkable efficac y and safety profile and does not require particular screening or follow-up blood tests. 1 The main criticism seems to be its slower activity, in terms of the time required for improvement, with a low rate of Psoriasis Area and Severity Index (PASI) 75 achievement at week 16 in clinical trials: 33.1% of patients in ESTEEM1 and 28% of patients in ESTEEM2. Few real-world studies have investigated the profile of apremilast; [5] [6] [7] [8] [9] there have been no reports of efficacy after 8 weeks of treatment, which we valued as a PASI 50 achievement in 58% of patients and PASI 75 in 19%. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) doi = 10.1111/dth.13722 id = cord-355354-1zwgjfc7 author = Mutalik, Sharad D. title = Mask‐induced psoriasis lesions as Köebner phenomenon during COVID‐19 pandemic date = 2020-09-29 keywords = Köebner summary = key: cord-355354-1zwgjfc7 title: Mask‐induced psoriasis lesions as Köebner phenomenon during COVID‐19 pandemic cord_uid: 1zwgjfc7 It has been shown that the disruption of a functional and structural permeability barrier is critical for the appearance of psoriasis as Köebner reaction. 4 Accordingly, the importance of the rupturing of the epidermis in initiating the Köebner response has been well documented. Along F I G U R E 1 Well-defined plaque with silvery white scales F I G U R E 2 Face mask with ear loops European task force on contact dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions A case of goggle-mask-related impetigo at the time of the COVID-19 pandemic Koebner phenomenon in psoriasis. Stratum corneum structure and function correlates with phenotype in psoriasis Face mask-induced itch: a self-questionnaire study of 2,315 responders during the COVID-19 pandemic Wearing the N95 mask with a plastic handle reduces pressure 59 injury doi = 10.1111/dth.14323 id = cord-263882-s5oxr6es author = Najar Nobar, Niloufar title = Patients with specific skin disorders who are affected by COVID‐19: what do experiences say about management strategies? : A systematic review date = 2020-06-18 keywords = COVID-19; disease; patient summary = doi = 10.1111/dth.13867 id = cord-338754-xdid58vn author = Olisova, O. Yu title = Cutaneous manifestations in COVID‐19: a skin rash in a child date = 2020-05-30 keywords = COVID-19 summary = Yu; Anpilogova, E.M.; Shnakhova, L.M. title: Cutaneous manifestations in COVID‐19: a skin rash in a child Dr Recalcati made the first report on cutaneous manifestations in COVID-19 nearly a month ago 4 , and since then, several authors have also noticed COVID-19-associated skin rash in adults [5] [6] [7] [8] [9] . However, the data on COVID-19-associated skin disorders in children are scarce. On the second day of fever the PCR COVID-19 test was positive. On the third day of illness the fever dramatically ceased and the skin rash appeared. Along with fever and fatigue, these eruptions may be considered as the only clinical manifestation of these particular COVID-19 infections in children. Cutaneous manifestations in COVID-19: a first perspective Cutaneous manifestations in COVID-19: Lessons learned from current evidence Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection doi = 10.1111/dth.13712 id = cord-305966-a61v2615 author = Pourani, Mohammad Reza title = CD147 inhibitors as a treatment for melanoma: promising agents against SARS‐CoV‐2 infection date = 2020-10-24 keywords = CD147 summary = 1 The CD147 protein (known as basigin) is a transmembrane protein that has recently been suggested as a potential receptor for SARS-CoV-2. 2 Recent studies have reported that the spike protein of SARS-CoV-2 attaches to host cells via angiotensin-converting enzyme-2 (ACE-2) and CD147 receptors. 3 In fact, recent studies have suggested CD147 as a novel tumor marker in the early diagnosis of some cancers like head and neck squamous cell carcinoma and hepatocellular carcinoma. 8 In conclusion, considering the possible role of CD147 in the pathogenesis of COVID-19, CD147 inhibitors may be considered as promising treatments for SARS-CoV-2 infection. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement CD147-targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression FDA approved drugs with pharmacotherapeutic potential for SARS CoV-2 (COVID-19) therapy doi = 10.1111/dth.14449 id = cord-254580-nhpjvgt4 author = Ricardo, Jose W. title = Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID‐19 pandemic date = 2020-05-27 keywords = infection; psoriasis summary = doi = 10.1111/dth.13687 id = cord-320929-8h44wf36 author = Sarkar, Rashmi title = Webinars as a mode of e‐discussion by Indian dermatologists during the COVID‐19 era: A boon or a bane? date = 2020-08-21 keywords = webinar summary = A live presentation, recorded video, or lecture broadcast online in real-time using the software defines ''webinar''. [3, 4] Online webinars make it interesting for the speakers as well as for the participants in the following ways: Hence webinar is like a ''double-edged sword'' which can be beneficial for some while others (non-qualified healthcare workers and those practicing traditional medicine) can misuse it by implementing the information incorrectly on patients (they are mostly not aware about pharmacokinetics, pharmacodynamics, interactions and contraindications of allopathic medications), especially those without appropriate qualifications and knowledge. Webinars are definitely a game-changer, only if practiced and conducted ethically without doing much damage to the healthcare system. Transition to virtual learning during COVID-19 crisis in Iran: opportunity or challenge Medical Students'' Perceptions and an Anatomy Teacher''s Personal Experience Using an e-Learning Platform for Tutorials During the Covid-19 Crisis Will Virtual Teaching Continue After the COVID-19 Pandemic? doi = 10.1111/dth.14220 id = cord-347725-w03ef08b author = Schwartz, Robert A. title = Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine date = 2020-04-16 keywords = AGEP summary = title: Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine A severe cutaneous drug reaction resembling acute generalized exanthematous pustulosis resulting from ingestion of hydroxychloroquine has been documented. Severe potentially life-threatening cutaneous drug reactions are a huge concern, most specifically acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), generalized bullous fixed drug eruption, and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation Successful treatment of hydroxychloroquine-induced recalcitrant acute generalized exanthematous pustulosis with cyclosporine: case report and literature review A case of recalcitrant acute generalized exanthematous pustulosis with Sjogren''s syndrome: successfully treated with low-dose cyclosporine Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine doi = 10.1111/dth.13380 id = cord-303460-abutfxtf author = Searle, Tamara title = Screen rhytides: the cosmetic legacy of COVID‐19 date = 2020-08-21 keywords = patient summary = key: cord-303460-abutfxtf authors: Searle, Tamara; Ali, Faisal R.; Al‐Niaimi, Firas title: Screen rhytides: the cosmetic legacy of COVID‐19 date: 2020-08-21 journal: Dermatol Ther cord_uid: abutfxtf contraction may reduce the length of time that botulinum toxin exerts its effects, resulting in an increased demand for more sessions of botulinum toxin with shorter intervals between each treatment. The authors are observing a sharp increase and awareness of glabellar and lateral canthal lines with patients directly referring the effects to increased "screen activity". Emerging reports of patients self-administering botulinum toxin with black-market at home kits demonstrates some patients'' desperation, with devastating potential adverse effects. 3 COVID-19 lockdown restrictions necessarily prohibited access to most aesthetic injectable treatments and as cosmetic clinics start to reopen, cosmetic dermatologists are likely to have a backlog of patients. 4 We suggest cosmetic practitioners should assess for and treat wrinkles and other facial changes resulting from prolonged screen activities. doi = 10.1111/dth.14211 id = cord-279056-mmcoqtb5 author = Seirafianpour, Farnoosh title = Cutaneous manifestations and considerations in COVID‐19 pandemic: A systematic review date = 2020-07-08 keywords = COVID-19; cutaneous; patient; skin summary = BACKGROUND: COVID‐19 had a great impact on medical approaches among dermatologist OBJECTIVE: This systematic review focuses on all skin problems related to COVID‐19, including primary and secondary COVID‐related cutaneous presentations and the experts recommendations about dermatological managements especially immunomodulators usage issues METHOD: Search was performed on PubMed, Scopus, Embase and ScienceDirect. Totally 5 article were about skin drug reactions of COVID-19 treatments; two of them were original studies as case reports that were summarized in Table 7 (in the supplement file). In overall, non-infected non-at risk patients with immune-medicated dermatologic disorders under usage of immunosuppressive immunomodulator drugs like biologic agents are not needed to be alter regimen or discontine the therapies during pandemic, even these drugs may control the deteriorating cytokine storms also prevented disease flare-ups which both were associated with poorer outcomes and more complications in COVID-19 course, although strict adherence to quarantine and personal-social preventive hygiene performances are highly recommended especially in these groups of patients. doi = 10.1111/dth.13986 id = cord-305076-v56y5nyt author = Singh, Parmvir title = Disseminated Intravascular Coagulation: A Devastating Systemic Disorder of Special Concern with COVID‐19 date = 2020-07-23 keywords = COVID-19; DIC; patient summary = Clinical patterns with DIC are varied, exemplified by those identified with COVID-19, from petechial to acro-ischemia presentations including finger/toe cyanosis, skin bulla and dry gangrene, some resembling chilblains disease (Figures 1,2) 7 . 8, 15 Skin manifestations caused by thrombosis include acral cyanosis (25%) and gangrene (17%). 8 It is important to differentiate the thrombotic/coagulopathic vasculopathic acral ischemia as seen in DIC from chilblain-like lesions (blue "COVID toes"), also associated with the This article is protected by copyright. 1,24,43-46 COVID-19-associated DIC therapy should follow accepted strategy employing thromboembolic prophylaxis for critically ill hospitalized patients and standard supportive care measures 47 . Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study doi = 10.1111/dth.14053 id = cord-331687-o5031cxp author = Singh, Yogendra title = RAAS blockers in hypertension posing a higher risk towards the COVID‐19 date = 2020-05-02 keywords = ACE2 summary = Most of the hypertensive patients are assisted by angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) or both. A recently published study suggested that COVID-19 also uses ACE2 as a cellular entry receptor, as this was detected in the isolates of the bronchoalveolar lavage fluid of one of the critically ill patients 4 . There is enough evidence to believe that the Zoonotic COVID-19 is completely dependent on human ACE2 as a receptor for entry, thus having high replication potential in human cells. Thus, patients who adhere to RAAS blockers (assisted with ACEi or ARBs) are believed to have a higher risk towards the deadly viral attack of COVID-19, and progressively they must be switched on to other class of anti-hypertensive drugs. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody doi = 10.1111/dth.13501 id = cord-254628-706vpjsv author = Stewart, Claire R. title = Safeguarding Dermatologist Attendings and Residents Amid the COVID‐19 Pandemic: Focus on Special Populations date = 2020-06-03 keywords = COVID-19 summary = 1 Despite appropriate precautions to reduce transmission risk, many dermatology faculty, residents, staff, and their families are at increased risk for COVID-19 infection while caring for patients. As stay at home orders expire, delayed surgeries and in-person semi-urgent appointments will be scheduled, with increased patient volume and heightened COVID-19 infection risk. 2 Those with comorbidities, including hypertension, diabetes, and obesity, are at even higher risk for hospitalization substantiated by a case series of 5700 individuals hospitalized with confirmed COVID-19 infection. 5 While limited data is available on pregnant women with COVID-19, early reports and lessons from other severe respiratory infections, including Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome, suggest that pregnant women may be at increased risk for complications. To reduce risk of COVID-19 infection acquired in the workplace, we must maintain an adequate supply of personal protective equipment (PPE) and enforce social distancing. doi = 10.1111/dth.13749 id = cord-290137-3jyhc63d author = Szepietowski, Jacek C title = Mental health status of health care workers during the COVID‐19 outbreak in Poland: one region, two different settings date = 2020-06-17 keywords = Department summary = During the COVID-19 pandemic health care workers (HCW) have been demonstrated to have higher level of anxiety and depression (1) . (2) suggested that HCW of the departments with high-risk contact with SARS-CoV-2 infected patients demonstrated higher mental health impact. Here, we present our data on mental health status of HCW of two various departments, including university department of dermatology, in Wroclaw, Poland, having different settings. They were asked to fill in the following questionnaires: General Anxiety Disorder -7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9) and Hospital Anxiety and Depression Scale (HADS). Analysing the whole studied group anxiety was suspected among 29.2% (HADS-A) -45% (GAD-7), while depression in 14.2% (HADS-D) -20% (PHQ-9). Anxiety, assessed with HADS-A, and depression, evaluated with PHQ-9, was significantly more prevalent (p<0.01 for both scales) among HCW reporting chronic comorbidities ( Table 2) . doi = 10.1111/dth.13855 id = cord-344566-r75o7ips author = Temiz, Selami Aykut title = Evaluation Of Dermatology Consultations In The Era Of COVID19 date = 2020-05-22 keywords = COVID-19 summary = The number of cases that were suspected to have COVID‐19 was statistically significantly higher in consultations requested by the emergency department and intensive care unit, while there were no suspected cases in outpatient clinic consultations (P = 0.001). In our study, we wanted to evaluate the features such as how dermatology consultations were affected during the COVID-19 pandemic, which is well established in our daily practice, features of the patients consulted, and skin findings in patients with suspected disease. The number of cases that were suspected to have COVID-19 was statistically significantly higher in consultations requested by the emergency department and intensive care unit, while there were no suspected cases in outpatient clinic consultations (p=0.001). With respect to the dermatology consultations in the pre-pandemic literature, it was found that a skin biopsy was performed on 4-13% of the patients (8, 9, 10, 11, 12, 13) . Analysis of Consultation Cases Referred from Pediatrics Department to Dermatology Outpatient Clinic: Retrospective Study doi = 10.1111/dth.13642 id = cord-265052-hfuvm1oh author = Turan, Çağrı title = Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us? date = 2020-06-12 keywords = COVID-19; application; patient summary = doi = 10.1111/dth.13804 id = cord-264264-7j3xirfg author = TüRsen, Ümit title = CORONAVIRUS‐DAYS IN DERMATOLOGY date = 2020-04-15 keywords = COVID-19; soap; virus summary = doi = 10.1111/dth.13421 id = cord-351457-fzj3ciif author = Vezzoli, Pamela title = Cutaneous lupus erythematosus patients in a high‐epidemic COVID‐19 area, Bergamo, Italy date = 2020-06-07 keywords = patient summary = Dear editor, the current pandemic of coronavirus disease 2019 (COVID-19) has raised the interest in reporting the management''s experience with systemic lupus erythematosus (SLE) patients under long-term treatment with immunosuppressor drugs or hydroxychloroquine (HCQ). 5, 6 However, no data about the management of risk infection in cutaneous lupus erythematosus (CLE) during the current pandemic are present in the literature to date. Our hospital is located in a high-epidemic area of Lombardy: we decided to advice patients affected by SLE with cutaneous manifestations and CLE, to scrupulously comply with hygiene rules and protective devices use, to maintain social distancing, not to spontaneously suspend ongoing therapy and to inform the dermatologist in case of the onset of symptoms, as suggested This article is protected by copyright. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus doi = 10.1111/dth.13776 id = cord-274331-0i2opmcn author = Wang, Catherine J. title = COVID‐19 infection on IL‐23 inhibition date = 2020-07-14 keywords = patient summary = Given mild symptoms, the patient was discharged. The patient was discharged 1 week later on home quarantine. The patient in this manuscript has given informed consent to publication of his case details. In our case, the patient recovered from COVID-19 before his next scheduled risankizumab dose. However, more data needs to be obtained about biologics in COVID-19 patients, in particular whether or not biologic dosage timeline should be adjusted based on resolution of infection. A database to collect information on COVID-19 patients on biologic therapy and their outcomes would be instrumental to guide clinicians on best practices for now and in future pandemics. In conclusion, this case illustrates that IL-23 inhibition via biologic therapy in COVID-19 may not correlate with severe respiratory disease. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor doi = 10.1111/dth.13893 id = cord-277693-6lrawta5 author = Wang, Yuanzhuo title = Contributions of dermatologists to COVID‐19 research: a brief systematic review date = 2020-05-30 keywords = COVID-19; article summary = 298 articles were included and classified into cutaneous manifestations of COVID‐19, operating experience against COVID‐19, mechanisms and treatment of COVID‐19, disinfection and personal protective equipment(PPE)‐related skin diseases and other topics. 70 articles focused on cutaneous manifestations of COVID-19 (n=70), followed by the management on patients with common skin diseases (n=68), operating experience against COVID-19 (n=49), mechanisms and treatment of COVID-19 (n=34), disinfection and personal protective equipment(PPE)-related skin diseases (n=27) and other topics(n=50). This study systematically reviewed contributions of dermatologists to COVID-19 research. We hope this study may help dermatologists to have a better understanding of the mechanisms, management, and the cutaneous manifestations of COVID-19, the operating experience of dermatology clinics in the " red-zone" area, and to use disinfectant and personal protective equipment properly. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times doi = 10.1111/dth.13713